Leading Experts Endorse Bioheart's Muscle Stem Cell MyoCell Therapy
... our expenses; (iii) our ability to establish a distribution network for and commence distribution of certain products for which we have acquired distribution rights; (iv) our ability to timely and ...PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009
... In March 2008, PLC signed its first international distribution agreement for RenalGuard with Artech s.r.l., Cavezzo, Italy for distribution of its RenalGuard System into Italy, and in May ... S.A., headquartered in Barcelona, Spain, for the distribution of RenalGuard in Spain. About PLC Systems ...ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives
... ThermoGenesis announced the launch of its distribution agreement with Celling Technologies, an ... 2008, ThermoGenesis announced the signing of a distribution agreement with Austin, Texas-based Celling Technologies that covers distribution rights for the field of use in orthopedics ...Cambridge Laboratories Announces Approval of Tetrabenazine in Spain
... for Tetrabenazine in H1 2009 - Exclusive distribution Rights Granted in Finland (MediFront) and Taiwan (Giddi Pharma); distribution Contracts Renewed in Australia and New Zealand ... - Cambridge has signed a marketing and distribution agreement with Giddi Pharma of Taiwan. ...ABR-Affinity BioReagents to Exhibit in the U.S. Pavilion at Medica, November 14 - 17, 2007
... to fill any existing small gaps in our worldwide distribution network at Medica this year, with an eye toward ... back -- with no questions asked. Utilizing a distribution network encompassing over 55 nations, ... United States, as well as through an exclusive distribution partnership with Fisher Scientific, a division of ...'Best Week Ever' for Nothing But Nets
... recently touted the benefits of free mass distribution of nets as "a powerful way to quickly and ... 2004 to 2006 as a result of wide-spread net distribution and use. A $10 donation at ... more than 400,000 nets, including a recent distribution to provide full coverage for children ...Gen-Probe and DiagnoCure Amend Collaboration Agreement Surrounding PCA3-Based Prostate Cancer Tests
... 2003 license agreement, establishing new FDA submission milestones and key distribution arrangements to leverage the full market potential of the PCA3-based test ... or customer contracts, and (vi) we are dependent on third parties for the distribution of some of our products. The foregoing describes some, but not all, of ...Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
... systems, today announced an agreement with Johnson & Johnson LLC for distribution of Simbionix's simulators and related products. Johnson & ... LLC,and Simbionix." "In the last year, Simbionix has increased its distribution channels and its exposure to the international market, "explains Mr. Doron ...Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads
... Refining the choice of radioisotope(s), amount of activity and geographic distribution of the cement Sensitivity of the radiation dose distribution to variations in bone size, density and tumor type; differences in bone ...American Dairy Provides Business Update
... and provided CNN with a tour of our first class research, packaging and distribution center in Langfang, China. I believe this demonstrates that Feihe's brand ... Feihe Dairy is headquartered in Beijing, China, and has processing and distribution facilities in Kedong, Qiqihaer, Baiquan, Gannan, Shanxi, and Langfang. ...PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.
... Laser is the world's first TMR angina relief device cleared for commercial distribution by both the U.S. Food and Drug Administration and Japanese Ministry of Health, Labor and Welfare, and to obtain a CE Mark for distribution within the EU. Additional company information can be found at ...Lotus Pharmaceuticals, Inc.'s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
... Enze ("Lotus East") undertake the development, production, marketing and distribution of pharmaceutical products. Lotus East has some of the most advanced ... produced by other manufacturers in the PRC through an extensive national distribution network. Lotus owns ten pharmacies in Beijing through which it directly ...Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
... seeking certification to apply the CE Mark for commercial sale and distribution of the TGI 1200 as a tissue processing system within the European Union. ... Bioheart's Board of Directors. Study objectives included assessment of the distribution and phenotype of the transplanted ADSCs and complete macroscopic exam and ...Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea
... is a privately owned company specializing in marketing, sales, and distribution of healthcare-related products and services for the Korean market. In particular, the Company focuses on the marketing and distribution of laboratory-based diagnostic products and reagents, laboratory ...Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
... exclusive rights in the defined territory for the marketing, sales and distribution of ONCONASE. Alfacell will receive 50% of all sales in the territory. ... a division of Par Pharmaceutical, Inc. Strategic marketing and distribution agreements for ONCONASE have been secured with BL&H Co. Ltd. for Korea, ...Newly Published Study Shows OPKO's siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
... - Study Published in Journal Molecular Vision - - Results Show Good distribution of Bevasiranib to Retina and RPE Cells after a Single ... the eye, including extensive uptake into the retina. In two tissue distribution and pharmacokinetic studies in rabbits, results showed that bevasiranib ...Aida Announces New Anti-Cancer Drug Under Development
... strongly from the experience garnered in the research, manufacturing and distribution of Rh-Apo2L. About Aida Pharmaceuticals Aida Pharmaceuticals is a ... since March 1999, is headquartered in Hangzhou, China with manufacturing, distribution and sales points throughout mainland China. Aida is GMP certified in China ...PLC Systems Reports Fourth Quarter 2007 Results
... Inc., replacing Edwards Lifesciences as our exclusive U.S. TMR distribution partner. We had anticipated the transition would take some time, and our ... Laser is the world's first TMR angina relief device cleared for commercial distribution by both the U.S. Food and Drug Administration and Japanese Ministry of ...Kronos Announces First Quarter Business Update and Financial Results
... private label residential standalone air purifiers through the retailer's distribution channels. Actual purchases of the products are dependent on the successful ... for the retailer to actively market the Kronos air purifier through its distribution channels. In addition during the quarter, Kronos continued its ...Veto of California's Condoms in Prisons Bill: "Politics Over Public Health," Says AHF
... inmates, as specified. The bill would also have established, ... the distribution of those devices is not a crime nor shall it be deemed to encourage sexual ... 8 to 10 times greater than in the general population. "Existing condom distribution programs in jails in New York, Philadelphia, Washington, DC, San Francisco ...Globus Medical Raises $110 Million in Series E Financing Round
... financing, Globus is well positioned to continue to expand its sales and distribution force and extend its innovative product portfolio at a pace unmatched in ... of 2007, Globus Medical has dramatically expanded the company's sales and distribution footprint and introduced six new systems that represent significant ...BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
... announced today that AnGes MG, Inc. (AnGes), BioMarin's marketing and distribution partner in Japan, has submitted a Biologics License Application (BLA) for ... now to other parts of the world." BioMarin established a marketing and distribution agreement with AnGes in December 2006, through which AnGes obtained ...Cancer Centers of North Carolina Offers HDR Brachytherapy for Treatment of Cancerous Tumors
... needles or applicators inserted into a body cavity or directly into the tumor. A computer-controlled delivery system is used to optimize the dose distribution to the target. As a result of this precise delivery, the surrounding healthy tissue and critical organs are preferentially spared from high doses of ...Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study
... of the U.S. Food and Drug Administration and foreign government regulators and tax obligations and risks; the impact of temporarily suspending U.S. distribution of one of our key hip replacement products; product liability and intellectual property litigation losses; reductions in reimbursement levels from ...PTSD Associated With Higher Alzheimer's/Dementia Risk; Moderate Alcohol Consumption May Lower it
... as none, 1-7 drinks/week (light), 8-14 drinks/week (moderate), and more than 14 drinks/week (heavy). All types of alcohol were counted. The distribution of alcohol consumption per week was 0=42.6%; 1-7=38.2%; 8-14=9.4%; more than 14= 9.8%. Participants were examined every six months for up to ...Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
... from IMS National Prescription Data for the 12 month period ending December 2008. IMS expressly reserves all rights, including rights of copying, distribution and republication. ** IMS national prescription data from 1992-July 2006. (1) Asacol HD Package Insert (April 2009) (2) Hanauer SB et al. ...Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)
... (0.65). ARIKACE can be delivered through nebulization, which enables the small aerosol droplet size (1 to 5 microns) to facilitate more effective distribution in the lungs. Positive Phase II results were announced in June 2008 from a clinical trial in European CF patients with Pseudomonas lung ...